Citius Pharmaceuticals Inc
NASDAQ:CTXR
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Citius Pharmaceuticals Inc
NASDAQ:CTXR
|
US |
|
Molina Healthcare Inc
NYSE:MOH
|
US |
|
Interface Inc
NASDAQ:TILE
|
US |
|
Energy Recovery Inc
NASDAQ:ERII
|
US |
|
A
|
Active Biotech AB publ
STO:ACTI
|
SE |
|
Minerals Technologies Inc
NYSE:MTX
|
US |
|
Howmet Aerospace Inc
NYSE:HWM
|
US |
|
L
|
Lgi Ltd
ASX:LGI
|
AU |
|
Yum China Holdings Inc
NYSE:YUMC
|
CN |
|
A
|
Arizon RFID Technology Cayman Co Ltd
TWSE:6863
|
KY |
|
Amalgamated Bank
NASDAQ:AMAL
|
US |
|
Fair Isaac Corp
NYSE:FICO
|
US |
|
Capitol Federal Financial Inc
NASDAQ:CFFN
|
US |
Bankruptcy Probability
Citius Pharmaceuticals Inc's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Citius Pharmaceuticals Inc Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| US |
|
Citius Pharmaceuticals Inc
NASDAQ:CTXR
|
15.4m USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Eli Lilly and Co
NYSE:LLY
|
1T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Johnson & Johnson
NYSE:JNJ
|
556.9B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| JP |
|
Hisamitsu Pharmaceutical Co Inc
TSE:4530
|
70.4T JPY |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CH |
|
Roche Holding AG
SIX:ROG
|
248.4B CHF |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Merck & Co Inc
NYSE:MRK
|
297.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| UK |
|
AstraZeneca PLC
LSE:AZN
|
217.3B GBP |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CH |
|
Novartis AG
SIX:NOVN
|
228.2B CHF |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
265.3B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.3T DKK |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CA |
|
Nuvo Pharmaceuticals Inc
TSX:MRV
|
249.7B CAD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Citius Pharmaceuticals Inc's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Citius Pharmaceuticals Inc has total debt of 1m USD. This includes both short-term (1m USD) and long-term (0 USD) debt.
You can find a full breakdown on its Balance Sheet.
